Journals / Solunum / 2007 / Cilt: 9 - Sayı: 2

Steroid resistance in chronic obstructive pulmonary disease (histone acetylation and histone deacetylation)

Kronik obstrüktif akciğer hastalığında steroid direnci (histon asetilasyonu ve histon deasetilasyonu)

Journal
Solunum
Pages
117–122
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the role of histone acetylation/deacetylation mechanisms projected in steroid resistance in COPD and therapeutic implications were reported

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic obstructive pulmonary disease (COPD) is an increasing global health problem that is characterized by airflow limitation associated with an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking.
📊
Key Findings & Data:This inflammation is mediated by the increased expression of multiple inflammatory genes which is regulated by acetylation of core histones and this expression is supressed by deacetylation of these histones.
💡
Conclusion & Impact:In this review, the role of histone acetylation/deacetylation mechanisms projected in steroid resistance in COPD and therapeutic implications were reported
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:İlaç direnci · Histon deasetilaz · Steroidler

Abstract

Chronic obstructive pulmonary disease (COPD) is an increasing global health problem that is characterized by airflow limitation associated with an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking. Recently new sights into molecular basis of inflammation have shed light on the effectiveness of steroids on inflammatory disease and probable steroid resistance of inflammation. This inflammation is mediated by the increased expression of multiple inflammatory genes which is regulated by acetylation of core histones and this expression is supressed by deacetylation of these histones. In this review, the role of histone acetylation/deacetylation mechanisms projected in steroid resistance in COPD and therapeutic implications were reported

Özet

Kronik obstrüktif akciğer hastalığı (KOAH), başlıca sigara olmak üzere zararlı partiküllere ve gazlara karşı akciğerlerde gelişen inflamatuar yanıtla ilişkili hava akımı sınırlanması ile karakterize önemli bir sağlık sorunudur. Son zamanlarda inflamasyonun moleküler temelinin anlaşılması konusundaki ilerlemeler, steroidlerin inflamatuar hastalıklarda etkinliğinin ve KOAH da mevcut inflamasyonun steroidlere olası direnç nedenlerinin daha iyi anlaşılmasını sağlamıştır. Buna göre inflamasyon, kor histonlarinin asetilasyonu ile düzenlenen infiamatuar genlerin artmış ekspresyonu ile gerçekleşmekte, histonların deasetilasyonu ile de baskılanmaktadır. Bu derlemede, KOAH'da steroid direncinde rolü olduğu ileri sürülen histon asetilasyonu / deasetilasyonu mekanizmasındaki bozukluk ve buna yönelik tedavi yaklaşımları sunulmuştur.

🔖

Cite This Article

DEMİRTAŞ, Ş., TATLICIOĞLU, T. (2007). Steroid resistance in chronic obstructive pulmonary disease (histone acetylation and histone deacetylation). Solunum, Cilt: 9 - Sayı: 2, 117–122. https://ajindex.com/articles/314484

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Barnes PJ, Adcock İM, ItoK. Histone acetylation and deacetyiation: importance in inflammatory lung diseases. Eur Respir J 2005:25:552-63
  2. Global Initiative for chronic obstructive lung disease. Global strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report. US Department of Health and Human Services. Public Health Service, National Institutes of Health, National Hearth, Lung and Blood Institute. NIH Publication No.2701, April 21
  3. Global Initiative for chronic obstructive lung disease. Global strategy for the Diagnosis, Management, and Prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report. US Department of Health and Human Services. Public Health Service, National Institutes of Health, National Hearth, Lung and Blood Institute, 2006 4. Wouters EF. Chronic obstructive pulmonary disease
  4. Systemic effects of COPD. Thorax 2002; 57: 1067- 70
  5. Boots AW, Haenen GR, Bast A Oxidant metabolism in chronic obstructive pulmonary disease. Eur Respir J 2003; 46{suppl): 14-27
  6. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001; 34(suppl): 50- 9
  7. Calikoğlu M, Şahin G, Unlu A Ozturk C, Tamer U Ercan B, Kanik A Atik U. Leptin and TNF alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration (Herrlisheim) 2004; 71:45- 50
  8. Sin DD, Man SF. Impaired lung function and serum leptin in men and women with normal body weight population based study. Thorax 2003; 58: 695- 8
  9. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J 2003; 22: 672- 88
  10. Barnes PJ: Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515
  11. Hogg JC, Chu F, Utokaparch S, et al. The nature of smallairway obstruction in chronic obstructive pulmonary disease. New EngJ Med 2004; 350: 2645- 53
  12. Turato G, Di Stefano A Maestrelli P, et al. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Med 1995; 152: 1262-67
  13. Rutgers SR, Postma DS, ten Hacken NH, et al. On going airway inflamation in patients with COPD who do not currently smoke. Thorax 2000; 55: 12- 8
  14. Retamales I, Elliott WM, Meshi B, et al. Amplification of inflamation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164: 469- 73
  15. Domagala Kulawik J, M